U.S. markets closed

Clover Health Investments, Corp. (CLOV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.2100-0.0400 (-1.23%)
At close: 04:00PM EDT
3.2200 +0.01 (+0.31%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close3.2500
Bid3.2000 x 43500
Ask3.2500 x 36200
Day's Range3.0600 - 3.3700
52 Week Range1.9500 - 11.1300
Avg. Volume8,842,067
Market Cap1.533B
Beta (5Y Monthly)2.00
PE Ratio (TTM)N/A
EPS (TTM)-1.4060
Earnings DateNov 07, 2022 - Nov 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.58
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CLOV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Clover Health Investments, Corp
    Analyst Report: BlackBerry LimitedBlackBerry, once known for being the world’s largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communication for enterprises. The firm provides endpoint management and protection to enterprises, specializing in regulated industries like government, as well as embedded software to the automotive, medical, and industrial markets.
    Fair Value
    Economic Moat
    last monthMorningstar
View more
  • American City Business Journals

    Former Google exec Andrew Toy named CEO of Clover Health

    The announcement comes more than a year after Clover was purchased by Palo Alto-based Social Capital Hedosophia Holdings for $4.2 billion, making it the largest M&A deal in Nashville for 2021.

  • MarketWatch

    Clover Health stock drops after mixed earnings, announcement of impending CEO change

    Shares of Clover Health Investments Corp. , which offers insurance plans to Medicare Advantage members, were off more than 6% in after-hours trading Monday after the company delivered a mixed earnings report and disclosed that its chief executive would be stepping down from that post at year's end. The company posted a net loss of $104.2 million, compared with a loss of $317.6 million a year earlier. Clover Health did not offer an earnings-per-share figure in its release. Clover posted a loss on

  • GlobeNewswire

    Clover Health Reports Second Quarter 2022 Financial Results

    Second quarter total revenue was $846.7 million compared to $412.5 million in second quarter 2021 Lives under Clover Management grew to ~255,000 from ~129,000 year-over-year Second quarter Insurance (Medicare Advantage) Medical Care Ratio ("MCR") of 92.1% shows significant improvement year-over-year FRANKLIN, Tenn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to improving